Nucleosome assembly protein 1-like 1 (NAP1L1) in gastric cancer patients: a potential biomarker with diagnostic and prognostic utility

References

• Anderson NL, Anderson NG. 2002. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 1(11):845–867. doi:10.1074/mcp.r200007-mcp200
   PubMed Web of Science ®Google Scholar
• Attia M, Rachez C, Avner P, Rogner UC. 2013. Nucleosome assembly proteins and their interacting proteins in neuronal differentiation. Arch Biochem Biophys. 534(1–2):20–26. doi:10.1016/j.abb.2012.09.011
   PubMed Web of Science ®Google Scholar
• Aydin MA, et al. 2020. Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility. Eur Rev Med Pharmacol Sci. 24(20):10512–10517.
   PubMed Web of Science ®Google Scholar
• Bang Y-J, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, et al. 2010. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 376(9742):687–697. doi:10.1016/S0140-6736(10)61121-X
   PubMed Web of Science ®Google Scholar
• Clark J, Alvarez DF, Alexeyev M, King JAC, Huang L, Yoder MC, Stevens T. 2008. Regulatory role for nucleosome assembly protein-1 in the proliferative and vasculogenic phenotype of pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol. 294(3):L431–439. doi:10.1152/ajplung.00316.2007
   PubMed Web of Science ®Google Scholar
• Durães C, Almeida GM, Seruca R, Oliveira C, Carneiro F. 2014. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch. 464(3):367–378. doi:10.1007/s00428-013-1533-y
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. 2010. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17(6):1471–1474. doi:10.1245/s10434-010-0985-4
   PubMed Web of Science ®Google Scholar
• Emoto S, Ishigami H, Yamashita H, Yamaguchi H, Kaisaki S, Kitayama J. 2012. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer. 15(2):154–161. doi:10.1007/s10120-011-0091-8
   PubMed Web of Science ®Google Scholar
• Fassan M, Baffa R, Kiss A. 2013. Advanced precancerous lesions within the GI tract: the molecular background. Best Pract Res Clin Gastroenterol. 27(2):159–169. doi:10.1016/j.bpg.2013.03.009
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2012. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 v1.0. IARC CancerBase No. 11. [online]. [accessed 2020 Mar 18]. Available from: https://publications.iarc.fr/Databases/Iarc-Cancerbases/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012.
   Google Scholar
• Hudis CA. 2007. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med. 357(1):39–51. doi:10.1056/NEJMra043186
   PubMed Web of Science ®Google Scholar
• Kanda M, Fujii T, Takami H, Suenaga M, Inokawa Y, Yamada S, Nakayama G, Sugimoto H, Koike M, Nomoto S, et al. 2014. Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. Surg Today. 44(9):1692–1701. doi:10.1007/s00595-013-0752-9
   PubMed Web of Science ®Google Scholar
• Kulasingam V, Diamandis EP. 2008. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 5(10):588–599. doi:10.1038/ncponc1187
   PubMedGoogle Scholar
• Le Y, Kan A, Li Q-J, He M-K, Chen H-L, Shi M. 2019. NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma. Cancer Cell Int. 19(1):228. doi:10.1186/s12935-019-0949-0
   PubMed Web of Science ®Google Scholar
• Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. 2001. Clinical utility of CEA, CA 19‑9 and CA 72‑4 in the follow‑up of patients with resectable gastric cancer. Am J Surg. 181(1):16–19. doi:10.1016/s0002-9610(00)00549-3
   PubMed Web of Science ®Google Scholar
• McCole RB, Loughran NB, Chahal M, Fernandes LP, Roberts RG, Fraternali F, O'Connell MJ, Oakey RJ. 2011. A case-by-case evolutionary analysis of four imprinted retrogenes. Evolution. 65(5):1413–1427. doi:10.1111/j.1558-5646.2010.01213.x
   PubMed Web of Science ®Google Scholar
• Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL. 2006. Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg. 244(1):52–60. doi:10.1097/01.sla.0000217617.06782.d5
   PubMed Web of Science ®Google Scholar
• Mu J, Huang W, Tan Z, Li M, Zhang L, Ding Q, Wu X, Lu J, Liu Y, Dong Q, et al. 2017. Dopamine receptor D2 is correlated with gastric cancer prognosis. Oncol Lett. 13(3):1223–1227. doi:10.3892/ol.2017.5573
   PubMed Web of Science ®Google Scholar
• Nagashio R, Kuchitsu Y, Igawa S, Kusuhara S, Naoki K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Sato Y, et al. 2020. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma. Biomed Res. 41(3):149–159. doi:10.2220/biomedres.41.149
   PubMed Web of Science ®Google Scholar
• Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, Hioki K. 1994. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer. 73(11):2703–2708. doi:10.1002/1097-0142(19940601)73:11<2703::AID-CNCR2820731109>3.0.CO;2-X
   PubMed Web of Science ®Google Scholar
• Okada M, Hozumi Y, Ichimura T, Tanaka T, Hasegawa H, Yamamoto M, Takahashi N, Iseki K, Yagisawa H, Shinkawa T, et al. 2011. Interaction of nucleosome assembly proteins abolishes nuclear localization of DGKzeta by attenuating its association with importins. Exp Cell Res. 317(20):2853–2863. doi:10.1016/j.yexcr.2011.09.014
   PubMed Web of Science ®Google Scholar
• Parkin DM. 2006. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 118(12):3030–3044. doi:10.1002/ijc.21731
   PubMed Web of Science ®Google Scholar
• Roskoski R. 2014. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol Res. 79:34–74. doi:10.1016/j.phrs.2013.11.002
   PubMed Web of Science ®Google Scholar
• Schimmack S, Taylor A, Lawrence B, Alaimo D, Schmitz-Winnenthal H, Büchler MW, Modlin IM, Kidd M. 2014. A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases. Epigenetics Chromatin. 7(1):15. doi:10.1186/1756-8935-7-15
   PubMedGoogle Scholar
• Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, Ye G, Zhang X, Xiao B, Guo J, et al. 2014. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 120(21):3320–3328. doi:10.1002/cncr.28882
   PubMed Web of Science ®Google Scholar
• Simon HU, Mills GB, Kozlowski M, Hogg D, Branch D, Ishimi Y, Siminovitch KA. 1994. Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein-1-related gene product involved in the induction of cell proliferation. Biochem J. 297(Pt 2):389–397. doi:10.1042/bj2970389
   PubMedGoogle Scholar
• Su C, Li H, Peng Z, Ke D, Fu H, Zheng X. 2019. Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays. Oncol Lett. 17(1):247–255. doi:10.3892/ol.2018.9608
   PubMed Web of Science ®Google Scholar
• Tanaka T, Hozumi Y, Iino M, Goto K. 2017. NAP1L1 regulates NF-κB signaling pathway acting on anti-apoptotic Mcl-1 gene expression. Biochim Biophys Acta Mol Cell Res. 1864(10):1759–1768. doi:10.1016/j.bbamcr.2017.06.021
   PubMed Web of Science ®Google Scholar
• Tsugane S, Sasazuki S. 2007. Diet and the risk of gastric cancer: review of epidemiologica evidence. Gastric Cancer. 10(2):75–83. doi:10.1007/s10120-007-0420-0
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. 2016. Gastric cancer. Lancet. 388(10060):2654–2664. doi:10.1016/S0140-6736(16)30354-3
   PubMed Web of Science ®Google Scholar
• Xia S, Tang Q, Wang X, Zhang L, Jia L, Wu D, Xu P, Zhang X, Tang G, Yang T, et al. 2019. Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer. Oncol Lett. 18(5):5341–5349. doi:10.3892/ol.2019.10879
   PubMed Web of Science ®Google Scholar
• Yan Y, Yin P, Gong H, Xue Y, Zhang G, Fang B, Chen Z, Li Y, Yang C, Huang Z, et al. 2016. Nucleosome assembly protein 1-like 1 (Nap1l1) regulates the proliferation of murine induced pluripotent stem cells. Cell Physiol Biochem. 38(1):340–350. doi:10.1159/000438634
   PubMedGoogle Scholar
• Yong H, Zhu H, Zhang S, Zhao W, Wang W, Chen C, Ding G, Zhu L, Zhu Z, Liu H, et al. 2016. Prognostic value of decreased expression of RBM4 in human gastric cancer. Sci Rep. 6(1):28222. doi:10.1038/srep28222
   PubMed Web of Science ®Google Scholar
• Zhai W, Ma J, Zhu R, Xu C, Zhang J, Chen Y, Chen Z, Gong D, Zheng J, Chen C, et al. 2018. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis. Br J Cancer. 119(5):591–604. doi:10.1038/s41416-018-0196-5
   PubMed Web of Science ®Google Scholar